文献速递前列腺增生与排尿功能障碍

水蒸气热疗缓解BPH所致留置导尿的尿潴留

Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2019-11-18

该回顾性研究纳入38例因BPH完全尿潴留而依赖导尿的男性,接受Rezūm水蒸气热疗。37例可随访者中26例(70.3%)恢复自主排尿并拔管,中位拔管时间26天;不良事件少且轻微。提示该疗法可能为这类患者提供有效安全的替代选择。

要点

  • 水蒸气热疗可使70.3%的导尿依赖BPH尿潴留患者恢复自主排尿。
  • 中位拔管时间26天,26例中18例停用BPH药物。
  • 不良事件少且轻,包括排尿困难13%、肉眼血尿10.5%、尿路感染2.6%。

核心结论

  • 水蒸气热疗可能为完全尿潴留且依赖导尿的BPH患者提供有效且安全的替代手术方案。

研究设计与样本

  • 回顾性分析两个中心连续纳入的38例因BPH完全尿潴留而依赖导尿的男性,中位年龄75.5岁,中位前列腺体积58.5 cc(23-153),中位导尿依赖时间3个月(0.3-35),中位2次失败的无导尿试验。

主要发现

  • 37例可随访患者中26例(70.3%)恢复自主排尿并拔管,平均需1.6±0.8次无导尿试验,中位拔管时间26天(范围4-65)。
  • 26例恢复排尿者中18例(69%)停用BPH药物。
  • 年龄、前列腺体积、水蒸气注射次数或中叶存在与否与治疗成功无显著差异。
  • 20例无导尿患者中位随访475天(140-804天),6例中位随访31.5天(0-60天)。
  • 不良事件包括排尿困难5例(13%)、肉眼血尿4例(10.5%)、尿路感染2例(2.6%),均轻微且迅速缓解。

临床怎么用

  • 对于因BPH完全尿潴留而依赖导尿、合并多种疾病者,可考虑水蒸气热疗以恢复自主排尿。
  • 治疗可在门诊手术中心清醒镇静或诊室改良前列腺周围阻滞下进行,注射方案根据增生腺体配置定制。

局限性

  • 回顾性设计、样本量小(38例),随访时间不一,部分患者随访较短。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Water vapor thermal therapy utilizes convectively delivered thermal energy to target ablation of obstructive prostatic tissue. We report results of this thermal therapy for relief of nonneurogenic complete urinary retention associated with BPH. PATIENTS AND METHODS: We conducted a retrospective analysis of 38 catheter-dependent men with complete urinary retention consecutively enrolled in a registry in two centers: median age 75.5 years and multiple comorbidities, median prostate volume 58.5 cc (23-153), median 2 failed trials without catheter (TWOCs), and median catheter dependency 3 months (0.3-35). The Rezūm™ System thermal therapy procedure was performed in an ambulatory surgery center with conscious sedation or an office procedure room with a modified periprostatic block. Water vapor injections were customized to the configuration of the hyperplastic gland, including median lobe and/or enlarged central zone. RESULTS: Of the 38 treated patients, one was lost to follow-up and 26 of 37 (70.3%) voided spontaneously (mean of 1.6 ± 0.8 TWOCs) and were catheter free a median of 26 days (range 4-65) after the procedure; 18 of these 26 (69%) patients discontinued BPH medications. No significant differences in age, prostate volume, number of water vapor injections, or presence of the median lobe were associated with predicting a successful treatment outcome. Duration of follow-up for 20 catheter-free patients was a median of 475 days or 15.8 months (140-804 days); six patients were followed a median of 31.5 days (0-60). Adverse events were infrequent, mild, and resolved quickly including dysuria in five patients (13%), gross hematuria in four (10.5%), and UTIs in two (2.6%) with indwelling catheters. CONCLUSIONS: Water vapor thermal therapy may provide an effective and safe alternative to surgical treatment in this group of catheter-dependent patients in complete urinary retention.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. McVary KT, Holland B, Beahrs JR, et al. Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2019. PMID: 31740738. doi:10.1038/s41391-019-0187-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。